NCT00199745View on ClinicalTrials.gov

Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Muscular Diseases
Interventions
DRUG

atorvastatin

Trial Locations (1)

0027

Lipidklinikken, Rikshospitalet-Radiumhospitalet HF, Oslo

All Listed Sponsors
collaborator

University of Oslo School of Pharmacy

OTHER

lead

Oslo University Hospital

OTHER

NCT00199745 - Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity | Biotech Hunter | Biotech Hunter